Global Demineralized Allografts Market Will Reach 940 Million USD in 2022
In the last several years, global market of demineralized allografts developed rapidly, with an average growth rate of 9%. In 2016, global revenue of demineralized allografts is nearly 567 M USD; the actual production is about 16.9 million units. https://www.qyresearch.com/index/detail/87408/global-demineralized-allografts-market
In the last several years, global market of demineralized allografts developed rapidly, with an average growth rate of 9%. In 2016, global revenue of demineralized allografts is nearly 567 M USD; the actual production is about 16.9 million units.
https://www.qyresearch.com/index/detail/87408/global-demineralized-allografts-market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Global</strong> <strong>Dem<strong>in</strong>eralized</strong> <strong>Allografts</strong><br />
<strong>Market</strong> <strong>Will</strong> <strong>Reach</strong> <strong>940</strong> <strong>Million</strong><br />
<strong>USD</strong> <strong>in</strong> <strong>2022</strong><br />
QYRESEARCH FOCUS ON MARKET SURVEY AND RESEARCH<br />
www.qyresearch.com
Beij<strong>in</strong>g Hengzhou Bozhi International<br />
Information Consult<strong>in</strong>g<br />
Web: qyresearchglobal.com | qyresearch.com<br />
TEL:+86-13660489419, Office:+86-2086655165<br />
Media: press@qyresearch.com<br />
<strong>Market</strong><strong>in</strong>g: sales@qyresearchglobal.com<br />
Facebook: @QYResearchOfficial,<br />
Twitter: @QYResearch_<br />
Wechat Official Account: QYResearch, Weibo: 恒 州 博 智<br />
www.qyresearch.com
QYResearch<br />
• <strong>Dem<strong>in</strong>eralized</strong> <strong>Allografts</strong> is tissue harvested from one <strong>in</strong>dividual and<br />
implanted <strong>in</strong>to another of the same species. In a search for an adequate<br />
substitute for autogenous bone, cadaveric allograft has been a viable option.<br />
Structural and morselized forms are available and prepared as either freshfrozen<br />
or freeze-dried. These grafts provide a structural framework or<br />
scaffold for host tissue to grow, hence mak<strong>in</strong>g allograft osteoconductive.<br />
Conversely, its osteo<strong>in</strong>ductive properties are mediocre at best. Upon<br />
implantation, the host is expected to experience an <strong>in</strong>tricate immune response.<br />
Freez<strong>in</strong>g or freeze-dry<strong>in</strong>g the allograft is crucial <strong>in</strong> m<strong>in</strong>imiz<strong>in</strong>g this reaction;<br />
however, the fundamental properties of the material may be altered.<br />
www.qyresearch.com
QYResearch<br />
• In the last several years, global market of dem<strong>in</strong>eralized allografts developed<br />
rapidly, with an average growth rate of 9%. In 2016, global revenue of<br />
dem<strong>in</strong>eralized allografts is nearly 567 M <strong>USD</strong>; the actual production is about<br />
16.9 million units.<br />
• The global average price of dem<strong>in</strong>eralized allografts is <strong>in</strong> the decreas<strong>in</strong>g trend,<br />
from 34.9 <strong>USD</strong>/Unit <strong>in</strong> 2012 to 33.4 <strong>USD</strong>/Unit <strong>in</strong> 2016. With the situation of<br />
global economy, prices will be <strong>in</strong> decreas<strong>in</strong>g trend <strong>in</strong> the follow<strong>in</strong>g five years.<br />
• The classification of dem<strong>in</strong>eralized allografts <strong>in</strong>cludes gel, putty and putty with<br />
chips, and the proportion of putty <strong>in</strong> 2016 is about 46%, and the proportion is <strong>in</strong><br />
decreas<strong>in</strong>g trend from 2012 to 2016.<br />
www.qyresearch.com
QYResearch<br />
<strong>Dem<strong>in</strong>eralized</strong> allografts are widely used <strong>in</strong> dental, sp<strong>in</strong>e surgery and trauma surgery. The<br />
most proportion of dem<strong>in</strong>eralized allografts is trauma surgery, and the consumption<br />
proportion is about 42%.<br />
North America region is the largest supplier of dem<strong>in</strong>eralized allografts, with a production<br />
market share nearly 90% <strong>in</strong> 2016. Europe is the second largest supplier of dem<strong>in</strong>eralized<br />
allografts, enjoy<strong>in</strong>g production market share nearly 8% <strong>in</strong> 2016.<br />
North America is the largest consumption place, with a consumption market share nearly 45%<br />
<strong>in</strong> 2016. Follow<strong>in</strong>g North America, Europe is the second largest consumption place with the<br />
consumption market share of 39%.<br />
www.qyresearch.com<br />
www.qyresearch.com
QYResearch<br />
<strong>Market</strong> competition is <strong>in</strong>tense. Medtronic, J &J (DePuy Synthes), Zimmer, Stryker<br />
Corporation, Straumann, RTI Surgical, Surgical Esthetics are the leaders of the<br />
<strong>in</strong>dustry, and they hold key technologies and patents, with high-end customers; have<br />
been formed <strong>in</strong> the monopoly position <strong>in</strong> the <strong>in</strong>dustry.<br />
The <strong>Global</strong> <strong>Dem<strong>in</strong>eralized</strong> <strong>Allografts</strong> <strong>Market</strong> Research Report 2018 report released by<br />
QYResearch provides a basic overview of the <strong>Dem<strong>in</strong>eralized</strong> <strong>Allografts</strong> <strong>in</strong>dustry,<br />
<strong>in</strong>clud<strong>in</strong>g def<strong>in</strong>ition, classification, application and <strong>in</strong>dustrial cha<strong>in</strong> structure. Discuss<br />
development policies and plans as well as manufactur<strong>in</strong>g processes and cost structures.<br />
Click to view the full report:<br />
https://www.qyresearch.com/<strong>in</strong>dex/detail/87408/global-dem<strong>in</strong>eralized-allografts-market<br />
www.qyresearch.com<br />
www.qyresearch.com
QYResearch<br />
The report then focuses on major <strong>in</strong>dustry players <strong>in</strong> <strong>Global</strong>, <strong>in</strong>clud<strong>in</strong>g company<br />
profiles, product images and specifications, sales, market share, and contact<br />
<strong>in</strong>formation. More importantly, the <strong>Dem<strong>in</strong>eralized</strong> <strong>Allografts</strong> <strong>in</strong>dustry development<br />
trends and market<strong>in</strong>g channels were analyzed. Provid<strong>in</strong>g the ma<strong>in</strong> statistical data on<br />
the current status of the <strong>in</strong>dustry is a valuable guide and direction for companies and<br />
<strong>in</strong>dividuals <strong>in</strong>terested <strong>in</strong> the market.<br />
About Us: QY Research established <strong>in</strong> 2007, focus on custom research, management<br />
consult<strong>in</strong>g, IPO consult<strong>in</strong>g, <strong>in</strong>dustry cha<strong>in</strong> research, data base and sem<strong>in</strong>ar services. The<br />
company owned a large basic data base (such as National Bureau of statistics database,<br />
Customs import and export database, Industry Association Database etc), expert’s<br />
resources (<strong>in</strong>cluded energy automotive chemical medical ICT consumer goods etc.<br />
www.qyresearch.com<br />
www.qyresearch.com
QYResearch<br />
Contact US<br />
QY Research, INC.<br />
17890 Castleton, Suite 218,<br />
City of <strong>in</strong>dustry, CA - 91748<br />
USA: +1 626 295 2442<br />
Email – sales@qyresearchglobal.com<br />
Web – www.qyresearch.com<br />
For other region, contact number given below<br />
+86 108 294 5717 Beij<strong>in</strong>g<br />
+86 208 665 5165 Guangzhou<br />
+86 215 160 1757 Shanghai<br />
+852 3062 8839 HK<br />
+1 613 366 5094 Canada<br />
+81 903 800 9273 Japan<br />
+49 176 813 78371Germany<br />
+44 203 734 8135 UK<br />
+33 172 813 308 France<br />
+55 613 181 0478 Brazil<br />
+91 114 046 9822 India<br />
+82 704 784 4013 Korea<br />
+65 315 821 22 S<strong>in</strong>gapore<br />
www.qyresearch.com
Change language